Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Hikari Heights-Varus Co's 3-Year RORE % for the quarter that ended in Mar. 2026 was 62.80%.
The industry rank for Hikari Heights-Varus Co's 3-Year RORE % or its related term are showing as below:
SSE:2137's 3-Year RORE % is ranked better than 86.21% of 602
companies
in the Healthcare Providers & Services industry
Industry Median: 0.35
vs SSE:2137: 62.80
Hikari Heights-Varus Co (SSE:2137) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Hikari Heights-Varus Co 3-Year RORE % Related Terms
Hikari Heights-Varus Co 3-Year RORE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SSE:2137 vs HCA, THC, DVA: 3-Year RORE % Comparison
For the Medical Care Facilities subindustry, Hikari Heights-Varus Co's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hikari Heights-Varus Co 3-Year RORE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hikari Heights-Varus Co's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Hikari Heights-Varus Co's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.
Hikari Heights-Varus Co (SSE:2137) has a 3-Year RORE % of 62.80 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Hikari Heights-Varus Co and its competitors. According to the industry distribution chart, Hikari Heights-Varus Co ranks #83 out of 602 companies in the Healthcare Providers & Services industry, placing it in the top 13.8%.
Is Hikari Heights-Varus Co's 3-Year RORE % too high?
Hikari Heights-Varus Co's current 3-Year RORE % is 62.80. The Healthcare Providers & Services industry median 3-Year RORE % is 0.35. Hikari Heights-Varus Co's value of 62.80 is 17842.9% above this industry median. Based on the distribution chart, Hikari Heights-Varus Co ranks #83 out of 602 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Hikari Heights-Varus Co has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hikari Heights-Varus Co's 3-Year RORE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Hikari Heights-Varus Co ranks #83 out of 602 companies for 3-Year RORE %. This places Hikari Heights-Varus Co in the top 14% of its industry — outperforming the majority of peers. The industry median 3-Year RORE % is 0.35. Hikari Heights-Varus Co's value of 62.80 is 17842.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.35, based on 602 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hikari Heights-Varus Co's current 3-Year RORE % of 62.80 is 17842.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Hikari Heights-Varus Co and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hikari Heights-Varus Co's current 3-Year RORE % is 62.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hikari Heights-Varus Co stock overvalued right now?
Based on GuruFocus' analysis, Hikari Heights-Varus Co (SSE:2137) is currently considered Fairly Valued. The stock's GF Value™ is 円730.36, compared to a current price of 円720.00 — trading 1.4% below its estimated fair value. The current 3-Year RORE % is 62.80 and 17842.9% above the Healthcare Providers & Services industry median of 0.35. Hikari Heights-Varus Co's overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Hikari Heights-Varus Co (SSE:2137), the current 3-Year RORE % is 62.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hikari Heights-Varus Co (SSE:2137) Overvalued in 2026?
Based on GuruFocus' analysis, Hikari Heights-Varus Co stock appears to be undervalued.
The current stock price of 円720.00 is trading 1.4% below its estimated GF Value™ of 円730.36.
GuruFocus considers Hikari Heights-Varus Co to be Fairly Valued.
Key valuation signals for SSE:2137:
3-Year RORE %: 62.80
GF Value™: 円730.36 vs. price of 円720.00 (1.4% below fair value)
Industry Position: 17842.9% above the Healthcare Providers & Services median (#83 of 602)
No single metric tells the full story. See the SSE:2137 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hikari Heights-Varus Co Ltd is a Japanese firm engaged in operating senior homes. It operates nursing homes for the elderly. The company provides rooms for healthy elderly as well as ones requiring assisted living.
58GF Score
Get the complete analysis for SSE:2137
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SSE:2137 has been successfully added to your 
